TripBuilder targets docs with iFoldz

Share this article:
Westport, CT-based TripBuilder, Inc., is determined to help drug and medical device companies educate physicians about new products while at the same time remain consistent with new PhRMA code guidelines.
TripBuilder's iFoldz combines a pharma company's message in a pocket-size, foldout credit card format. iFoldz is a communications vehicle for product launches, product instructions and safety information. 

TripBuilder officials claim that the iFoldz delivers a pharma company's educational message cost-effectively as well as fills a void in the market left by standard logoed items such as pens and mugs that have limited space to convey large amounts of information and do not have an educational component mandated by the new PhRMA  code. 

Steven Tanzer, EVP of TripBuilder said that the new PhRMA Code limits what drug companies can hand out to docs. “iFoldz are a fully PhRMA compliant and a memorable way to deliver the pharma company's message and it's fully consistent with the PhRMA code because the piece is 100% educational.” He noted that the compact size and expanding design allow for a large amount of custom information to fit into a pocket.  

Tanzer said that Roche has used iFoldz to deliver information on how to use its AccuCheck blood glucose system. Tanzer said that among other things, iFoldz can be used to target a specific medical niche such as diabetes specialists and deliver educational messages to physicians attending medical trade shows for instance. The compact format and size, said Tanzer, makes them very easy to hold on to and enhances retention.  

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.